Education
About Us
Working with TipRanks
Follow Us
Burning Rock Biotech Ltd. (BNR)
NASDAQ:BNR
RESEARCH TOOLSreports
Total Valuation
Burning Rock Biotech has a market cap or net worth of $30.67M. The enterprise value is -$449.41M.
Market Cap$30.67M
Enterprise Value-$449.41M
Share Statistics
Burning Rock Biotech has 8,232,740 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding8,232,740
Owned by Insiders―
Owned by Institutions16.17%
Financial Efficiency
Burning Rock Biotech’s return on equity (ROE) is -0.60 and return on invested capital (ROIC) is -56.52%.
Return on Equity (ROE)-0.60
Return on Assets (ROA)-0.39
Return on Invested Capital (ROIC)-56.52%
Return on Capital Employed (ROCE)-0.58
Revenue Per Employee765.31K
Profits Per Employee-514.28K
Employee Count674
Asset Turnover0.58
Inventory Turnover2.85
Valuation Ratios
The current PE Ratio of Burning Rock Biotech is -1.47. Burning Rock Biotech’s PEG ratio is 0.02.
PE Ratio-1.47
PS Ratio0.00
PB Ratio0.30
Price to Fair Value0.88
Price to FCF-0.18
Price to Operating Cash Flow-1.89
PEG Ratio0.02
Income Statement
In the last 12 months, Burning Rock Biotech had revenue of 515.82M and earned -346.63M in profits. Earnings per share was -335.60.
Revenue515.82M
Gross Profit362.40M
Operating Income-357.56M
Pretax Income-340.74M
Net Income-346.63M
EBITDA-270.23M
Earnings Per Share (EPS)-335.60
Cash Flow
In the last 12 months, operating cash flow was -92.26M and capital expenditures 0.00, giving a free cash flow of -98.24M billion.
Operating Cash Flow-92.26M
Free Cash Flow-98.24M
Free Cash Flow per Share-11.93
Dividends & Yields
Burning Rock Biotech pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.18
52-Week Price Change-63.37%
50-Day Moving Average3.81
200-Day Moving Average4.98
Relative Strength Index (RSI)43.91
Average Volume (3m)51.86K
Important Dates
Burning Rock Biotech upcoming earnings date is Jun 3, 2025, TBA Not Confirmed.
Last Earnings DateMar 25, 2025
Next Earnings DateJun 3, 2025
Ex-Dividend Date―
Financial Position
Burning Rock Biotech as a current ratio of 2.92, with Debt / Equity ratio of 9.01%
Current Ratio2.92
Quick Ratio2.71
Debt to Market Cap0.00
Net Debt to EBITDA1.73
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Burning Rock Biotech has paid 5.88M in taxes.
Income Tax5.88M
Effective Tax Rate-0.02
Enterprise Valuation
Burning Rock Biotech EV to EBITDA ratio is -17.10, with an EV/FCF ratio of -47.04.
EV to Sales8.96
EV to EBITDA-17.10
EV to Free Cash Flow-47.04
EV to Operating Cash Flow-50.09
Balance Sheet
Burning Rock Biotech has $519.85M in cash and marketable securities with ¥52.32M in debt, giving a net cash position of -$467.53M billion.
Cash & Marketable Securities$519.85M
Total Debt¥52.32M
Net Cash-$467.53M
Net Cash Per Share-$56.79
Tangible Book Value Per Share$5.62
Margins
Gross margin is 70.26%, with operating margin of -69.32%, and net profit margin of -67.20%.
Gross Margin70.26%
Operating Margin-69.32%
Pretax Margin-66.06%
Net Profit Margin-67.20%
EBITDA Margin-52.39%
EBIT Margin-62.51%
Analyst Forecast
The average price target for Burning Rock Biotech is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.72%
EPS Growth Forecast48.12%